ReviewFrontiers in oncology2021

Are All Anti-Angiogenic Drugs the Same in the Treatment of Second-Line Metastatic Colorectal Cancer? Expert Opinion on Clinical Practice.

Eleonora Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.